SHAREHOLDER ALERT: TXT SNDL MGNX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / October 7, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Textron Inc. (NYSE:TXT)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/textron-inc-loss-submission-form?prid=3849&wire=1
Lead Plaintiff Deadline: October 21, 2019
Class Period: January 31, 2018 to October 17, 2018

Allegations against TXT include that: (1) end market sales of Arctic Cat products were slowing, resulting in a massive glut of old Arctic Cat inventory on dealers' floors; (2) in order to clear out this old inventory, the Company provided significant price discounts, which negatively impacted Textron's earnings; and (3) as a result, Textron's positive statements about Arctic Cat's business, operations, and prospects lacked a reasonable basis.

Sundial Growers Inc. (NASDAQ:SNDL)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/sundial-growers-inc-loss-submission-form?prid=3849&wire=1
Lead Plaintiff Deadline: November 25, 2019
Class Period: pursuant and/or traceable to the registration statement issued in connection with Sundial's August 1, 2019 initial public stock offering.

Allegations against SNDL include that: (1) Sundial failed to supply saleable cannabis in line with contractual obligations to Zenabis Global Inc.; (2) due to material quality issues, Zenabis had to return or reject a total of 554 kg of cannabis to Sundial, valued at approximately U.S. $1.9 million (C$2.5 million); and (3) as a result, defendants' statements about Sundial's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

MacroGenics, Inc. (NASDAQGS:MGNX)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/macrogenics-inc-loss-submission-form?prid=3849&wire=1
Lead Plaintiff Deadline: November 12, 2019
Class Period: February 6, 2019 to June 3, 2019

Allegations against MGNX include that: (a) the Company had conducted the progression-free survival ("PFS") and first interim overall survival ("OS") analyses for the SOPHIA trial by no later than October 10, 2018; (b) the October 2018 PFS analysis showed a 0.9 month improvement in PFS; and (c) the October 2018 OS interim analysis did not produce a statistically significant result and the interim OS Kaplan-Meier curves crossed in several spots (thereby violating the constant hazard assumption) and separated late.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 562404